First Amendment takes center stage in DTC price fight

A string of court decisions in recent years has handed the pharmaceutical industry wins in an ongoing legal fight over the promotion and marketing of prescription drugs.

That streak could be tested again, as the Trump administration seeks to compel pharmas to reveal list prices in their direct-to-consumer advertising.